Dr. Roel Van Roy SRL
Dr. Roel Van Roy reported total assets of €1.00m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jan 2026).
The score of Dr. Roel Van Roy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +22 % Total assets +41 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Roel Van Roy's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 175,701 € | ||||
| Equity | 870,036 € | ||||
| Cash | 230,329 € | ||||
| EBITDA | 237,227 € | ||||
| Total assets | €1.00m |
Filed annual accounts
- Year ended 30 Jun 2025filed on 14 Jan 2026
- Year ended 30 Jun 2024filed on 16 Dec 2024
- Year ended 30 Jun 2023filed on 04 Dec 2023
- Year ended 30 Jun 2022filed on 21 Dec 2022
- Year ended 30 Jun 2021filed on 29 Nov 2021
Dr. Roel Van Roy's financial analysis
- Solvency87.0%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Roel Van Roy
Dr. Roel Van Roy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0827.038.628
- VAT number
- BE0827038628
- Peppol
- Registered · 0208:0827038628 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jun 2010
- Registered office
- 2640 Mortsel
- Latest accounts
- 2025 · filed on 14 Jan 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Roel Van Roy (SRL) has been based in Mortsel since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 175,701 € and equity of 870,036 €; its revenue is not published. Its solvency stands at 87.0%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Roel Van Roy
Companies in the same business, of comparable size and area, outside its group.
- Pontibus Intermediation service activities for real estate activities Rumst · balance sheet €1.00m
- Condoco Rental and operating of own or leased real estate Antwerp · balance sheet €1.00m
- Marguylux Halle · balance sheet 999,627 €
- Invest Consulting Business and other management consultancy activities Ghent · balance sheet 999,126 €
- Lesco Vastgoed Buying and selling of own real estate Antwerp · balance sheet 964,156 €
- River Properties Buying and selling of own real estate Antwerp · balance sheet €1.00m
- Dr. Waterschoot A.M. Zottegem · balance sheet 999,936 €
Frequently asked questions about Dr. Roel Van Roy
What is the revenue of Dr. Roel Van Roy?
Dr. Roel Van Roy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Roel Van Roy?
In Belgium, the VAT number is the company number prefixed with BE: BE0827038628 for Dr. Roel Van Roy, if the company is VAT-registered. Its company number (CBE) is 0827.038.628.
Where is the registered office of Dr. Roel Van Roy?
According to the CBE register, the registered office of Dr. Roel Van Roy is in 2640 Mortsel.
What is the equity of Dr. Roel Van Roy?
At the close of the 2025 financial year, the equity of Dr. Roel Van Roy amounts to 870,036 €, a solvency of 87.0% of total assets.
Who manages Dr. Roel Van Roy?
The register lists 1 active mandates at Dr. Roel Van Roy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Roel Van Roy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →